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Calnexin is an endoplasmic reticulum (ER)-resident molecular chaperone that plays
an essential role in the correct folding of membrane proteins. We found that calnexin
is subjected to partial cleavage in apoptotic mouse cells. Both ER stress–inducing and
ER stress–non-inducing apoptotic stimuli caused the cleavage of calnexin, indicating
that this event does not always occur downstream of ER stress. The inhibition of cas-
pases that target the amino acid sequence DXXD abrogated calnexin cleavage in
apoptotic stimulus-treated cells. In addition, disruption of one of two DXXD
sequences located in the cytoplasmic domain caused calnexin to escape cleavage dur-
ing apoptosis. Furthermore, calnexin was cleaved in vitro by recombinant caspase-3
or caspase-7. Finally, the overexpression of a presumed cleavage product of calnexin
partly inhibited apoptosis. These results collectively suggest that caspase-3 or cas-
pase-7 cleaves calnexin, whose cleaved product leads to the attenuation of apoptosis.
Key words: apoptosis, calnexin, caspase, chaperone, ER stress.
Abbreviations: ER, endoplasmic reticulum; EGFP, enhanced green fluorescence protein; FITC, fluorescein isothio-
cyanate; PBS, phosphate-buffered saline; SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
The endoplasmic reticulum (ER) is the site of synthesis of
membrane and secretory proteins, and regulates protein
folding and trafficking, cellular responses to stress, and
intracellular calcium (Ca2+) levels (1). Alterations in Ca2+
homeostasis, the inhibition of N-linked glycosylation, and
chemical toxicants, oxidative stress, etc. cause ER stress
(2). When unfolded proteins accumulate and aggregate in
the ER, a signal emerges that selectively activates the
transcription of genes encoding ER chaperones to sup-
port correct protein folding, and inhibits protein synthe-
sis to reduce the burden of protein substrates for ER-fold-
ing. This phenomenon is the so-called unfolded protein
response (UPR) (3). Prolonged ER stress contributes to cell
death and is linked to the pathogenesis of several neuro-
degenerative disorders such as Alzheimer’s disease, Par-
kinson’s disease, and amyotrophic lateral sclerosis (2, 4).
The apoptotic process involves the activation of cas-
pases, a family of cysteine-dependent aspartate-directed
proteases (5, 6). The caspase family is broadly divided
into two groups: initiator caspases (caspase-8, -9, -10)
and effector caspases (caspase-3, -6, and -7) (6). Initiator
caspases undergo autoprocessing for activation in
response to apoptotic stimuli. Active initiator caspases in
turn process precursors of effector caspases responsible
for dismantling cellular structures. The localization of
caspases and the translocation of their active products
appear to be critical for the development of the apoptotic
process (6). Caspase-12 has been shown to be specifically
involved in apoptosis that results from stress in the ER
cation of caspase-7 to the ER surface, where it cleaves
caspase-12 (9). Prolonged ER stress results in the move-
ment of active caspase-12 to the cytoplasm, where it
interacts with caspase-9 (9).
Calnexin is a type I integral membrane protein with a
large ER luminal domain, a transmembrane domain, and
an ER-retention motif in its cytoplasmic tail (10). Cal-
nexin is a molecular chaperone distributed mainly in the
ER, that plays an essential role by interacting tran-
siently with a diverse array of membrane proteins early
in their synthesis (11). Calnexin promotes membrane
protein assembly by retaining intermediates in the ER
until the complete ternary complex is formed (12). In con-
trast, misfolded or incompletely assembled proteins show
a prolonged association with calnexin.
In the present study, we show that several apoptotic
stimuli cause the cleavage of calnexin in the carboxyl ter-
minal region. Moreover, expression of the cleaved car-
boxyl terminal region of calnexin attenuates apoptosis,
suggesting a novel mechanism of action during apoptosis.
EXPERIMENTAL PROCEDURES
Cell Culture—NIH3T3 and COS-1 cells were cultured
in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum, and maintained under 5%
CO2 at 37°C. Cells were transfected with 2 µg of plasmid
DNA per 5 × 105 cells using 6 µl of Lipofectamine-plus
and 4 µl of Lipofectamine (Invitrogen Corp., Carlsbad,
CA, USA) according to the manufacturer’s instructions.
NIH3T3 cells were infected with influenza virus A/WSN/
33 (H1N1) at a multiplicity of infection of 5 as described
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400 T. Takizawa et al.Plasmids and DNA Transfection—Mouse calnexin cDNA
was kindly provided by Dr. Larry W. Tjoelker (ICOS cor-
poration, Bothell, WA, USA). Mutant calnexin cDNAs
carrying a point mutation of D to E at position 527 or 568
were constructed by sequential polymerase chain reac-
tion (PCR) as described previously (14). Primers used in








mers PstI/for, BamHI/rev, and XhoI/for contain sites
cleavable by the restriction enzymes PstI, BamHI and
XhoI (underlined), respectively. BamHI/rev has a stop
codon before the BamHI site (bold letters). The primers
DVKE/for and DVKE/rev are complementary over 21
nucleotides, and contain one nucleotide change (bold let-
ter) that creates an amino acid substitution of D to E at
527. The primers DEEE/for and DEEE/rev are also com-
plementary over 21 nucleotides, and contain one nucle-
otide change (bold letter) that creates an amino acid sub-
stitution of D to E at 568. For the construction of DNA
encoding the DVKE sequence, the upstream DNA frag-
ment of DVKE was amplified using PstI/for and DVKE/
rev, and the downstream fragment was amplified with
DVKE/for and BamHI/rev. The resulting two DNA frag-
ments were then annealed, and a secondary PCR was
performed using PstI/for and BamHI/rev. For the con-
struction of DNA encoding DEEE, the upstream frag-
ment of DEEE was amplified using PstI/for and DEEE/
rev, and the downstream fragment was amplified with
DEEE/for and BamHI/rev. The resulting two DNA frag-
ments were subjected to a secondary PCR as described
above. These DNA fragments were digested with PstI
and BamHI, and subcloned into PstI/BamHI–digested
pEGFP-C3 to make fusion proteins with enhanced green
fluorescence protein (EGFP) (Clontech Laboratories, Inc.,
Palo Alto, CA, USA). For the construction of the fusion
protein containing the carboxyl terminal 45 amino acids,
the above DNA fragment containing DEEE was digested
with HindIII and BamHI, and subcloned into HindIII/
BamHI–digested pEGFP-C3. For the construction of the
fusion protein containing only the carboxyl terminal 25
amino acids, the DNA fragment was amplified using
primers XhoI/for and BamHI/rev, digested with XhoI and
BamHI, and subcloned into XhoI/BamHI–digested
pEGFP-C3. All the amplified DNA fragments were veri-
fied by DNA sequencing as described (15).
Indirect Immunofluorescence—Indirect immunofluores-
cence was performed as described (16). Briefly, cells were
fixed with 4% paraformaldehyde containing 0.2% Triton
X-100 in phosphate-buffered saline (PBS) for 30 min and
washed with PBS. Cells were then incubated with anti-
CHOP polyclonal antibody (Santa Cruz Biotechnologies,
Santa Cruz, CA, USA) at a dilution of 100 for 60 min,
stained with anti-rabbit immunoglobulin G antibody con-
jugated with fluorescein isothiocyanate (FITC) (MBL,
Nagoya, Japan) at a dilution of 200 for 60 min, and
observed under a fluorescence microscope at a magnifica-
tion of 400 (Axiovert 200M, Carl Zeiss Light Microscopy,
Gottingen, Germany). For the expression of EGFP, cells
were fixed with 4% paraformaldehyde, and observed
under a fluorescence microscope as described above.
Immunoblot Analyses—Cell extracts were prepared
with Laemli’s sample buffer (17) and boiled. Lysates were
resolved by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) and transferred onto nitro-
cellulose filters (Bio-Rad Laboratories, Hercules, CA,
USA). Filters were incubated with anti-calnexin (Stress-
Gen Biotechnologies Corp., Victoria, Canada) or anti-
GFP polyclonal antibody (Santa Cruz Biotechnologies) at
a dilution of 1,000 for 60 min followed by anti-rabbit
immunoglobulin antibody conjugated with peroxidase at
a dilution of 1,000 for 60 min. Signals were visualized
using an ECL detection system (Amersham Biosciences
K.K., Tokyo, Japan).
In Vitro Cleavage of Calnexin—Mouse calnexin cDNA
was transcribed and translated in vitro using a TNT kit
(Promega Corporation, Madison, WI, USA) in the pres-
ence of 35S-methionine (ICN Biomedicals, Inc., Costa
Mesa, CA, USA). In vitro synthesized calnexin was then
incubated with active recombinant caspases-Group II
(MBL) in a reaction mixture containing 50 mM HEPES,
Fig. 1. Cleavage of calnexin during
apoptosis. NIH3T3 cells incubated
with the indicated reagents were
lysed, and calnexin was detected by
Western blotting. The term “mock” in
A indicates that the cells were incu-
bated with PBS containing no virus.
Cells were incubated for 48 h in the
presence of the reagents indicated in
C–F. Cell lysates containing 20 µg of
protein were analyzed in each lane.
The arrowheads point to the positions
of putative cleaved products of cal-
nexin. The positions of molecular
mass markers are indicated on the
left.J. Biochem.
Calnexin Cleavage during Apoptosis 401pH 7.2, 50 mM NaCl, 0.1% Chaps, 10 mM EDTA, 5% glyc-
erol, and 10 mM dithiothreitol for 6 h at 37°C. Reactions
were resolved by SDS-PAGE followed by fluorography.
RESULTS
Apoptotic Stimuli Induce the Cleavage of Calnexin in
Cells—During an analysis of influenza virus–induced
apoptosis (18), we found that the ER-resident molecular
chaperone calnexin appeared to be degraded (Fig. 1A). To
investigate this event further, we examined several
inducers of apoptosis and ER stress for their effect on cal-
nexin degradation. All the reagents tested induced apop-
tosis in NIH3T3 cells as assessed by the occurrence of
DNA fragmentation (data not shown), and, at the same
time, faster migrating signals became detectable with
anti-calnexin antibodies (Fig. 1, B–F). The appearance of
these signals depended on the duration of incubation and
the dose of inducers. Treatment with influenza virus,
thapsigargin (a Ca2+-dependent ATPase inhibitor), or
tunicamycin (an inhibitor of glycosylation in the ER)
gave single cleaved products, while treatment with stau-
rosporine (protein kinase C inhibitor) or A23187 (calcium
ionophore) gave two products. These results indicate that
calnexin is cleaved during apoptosis as well as under ER
stress.
Since ER stress has been shown to induce the expres-
sion of the transcription factor C/EBP-homologue protein
(CHOP) (19), we examined the effect of the above stimuli
on CHOP expression using immunofluorescence micros-
copy (Fig. 2). Untreated NIH3T3 cells were negative for
CHOP expression, whereas treatment with tunicamycin
brought about fluorescence signals located in the
nucleus, indicating that CHOP expression is induced by
ER stress. The expression of CHOP was similarly
induced by treatment with thapsigargin or A23187, but
this was not the case in staurosporine-treated or influ-
enza virus–infected cells. Although staurosporine-
treated cells showed intense staining of the cytoplasm
due to cell rounding caused by this reagent, CHOP
expression was not observed by Western blotting (data
not shown). These results indicate that ER stress, at
least that accompanied by CHOP expression, is not
always prerequisite to the cleavage of calnexin.
Fig. 2. CHOP expression in cells treated with inducers of cal-
nexin cleavage. NIH3T3 cells were exposed to the indicated rea-
gents for 8 h and analyzed for the expression of CHOP by immun-
ofluorescence microscopy. Fluorescence and phase contrast images
of the same microscopic fields are shown at a magnification of 400.
Fig. 3. DEVDase-mediated cleavage of calnexin. NIH3T3 cells
were exposed to staurosporine (2 µM) or A23187 (2 µM) in the
absence (–) or presence of z-VAD-fmk (VAD, 40 µM), z-DEVD-fmk
(DEVD, 40 µM), Ac-YVAD-CHO (YVAD, 100 µM), or z-IETD-fmk
(IETD, 40 µM) for 48 h, and then lysates containing 20 µg of protein
were examined by western blotting with anti-calnexin antibody.
The arrowheads denote the position of a cleaved fragment of cal-
nexin.Vol. 136, No. 3, 2004
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are involved in the cleavage of calnexin, the effect of cas-
pase inhibitors was examined (Fig. 3). The pan-caspase
inhibitor, z-VAD-fmk, almost completely inhibited cal-
nexin cleavage induced by all the stimuli examined
above; the results with staurosporine and A23187 are
shown as examples. Another inhibitor, z-DEVD-fmk, also
inhibited the cleavage by staurosporine or A23187,
whereas Ac-YVAD-CHO and z-IETD-fmk had no effect.
Therefore, the activity of caspases, DEVDase in particu-
lar, is required, either directly or indirectly, for the cleav-
age caused by those stimuli.
Since the cytoplasmic domain of mouse calnexin con-
tains two amino-acid sequences identical to the consen-
sus sequence of group II caspases, DXXD (20), we antici-
pated that one or both of the sequences are the sites for
caspase-mediated cleavage. To examine this possibility,
we expressed EGFP fused to the carboxyl terminal region
containing both sequences in COS-1 cells and determined
the size of the fusion protein after staurosporine treat-
ment by immunoblotting using anti-GFP antibody. We
found that a faster migrating signal was present in cell
lysates together with a presumed full-length protein (Fig.
4B). When a fusion protein in which one of the two
sequences was disrupted was expressed, the protein with
the altered sequence nearer the carboxyl terminal was no
longer cleaved (Fig. 4B). To confirm this result, EGFP
fused to 45 amino acids of the carboxyl terminal region
containing only this sequence was tested. The fused pro-
tein expressed in COS-1 cells was cleaved upon stau-
rosporine treatment, and a D to E alteration of this
sequence abolished the cleavage (Fig. 4C). The same
results were obtained when cells were exposed to tuni-
camycin or thapsigargin (data not shown). Furthermore,
the fused protein was in vitro translated, and examined
for whether caspases directly cleave the putative target
sequence. Caspase-3 or caspase-7, even though to a lesser
extent, cleaved the fused protein but not that with a D to
E alteration (Fig. 4D). Full-length calnexin synthesized
in vitro was also directly cleaved by caspase-3 (Fig. 4E). A
very faint band could be observed in the case of caspase-
7. The caspase-3 and caspase-7 used in this study cleaved
a synthetic luminogenic substrate containing a DEVD
sequence to the same extent (data not shown), suggesting
that the different cleavability of calnexin is due to differ-
ent substrate specificities. These results indicate that
mouse calnexin is cleaved at 568D directly by a DEV-
Dase-like caspase(s) in apoptotic cells.
Cleaved Calnexin Attenuates Apoptosis—Since the
amount of endogenous calnexin in the intact form is
much greater than that of the cleaved form even in cells
exposed to apoptotic stimuli, it is very difficult to see the
effect of the endogenous cleaved product on apoptosis
directly. Therefore, we employed EGFP fused to the pre-
sumed cleaved fragment of calnexin between amino acids
567 and 591 to assess the biological role of the cleavage.
The calnexin-EFGP fusion protein was expressed in
NIH3T3 cells, and the extent of apoptosis in the cells was
Fig. 4. Identification of the cleav-
age site of mouse calnexin. (A)
Schematic representation of mouse
calnexin. Two sequences identical to
the consensus sequence for the group
II caspase, DEVDases are shown with
amino acid positions. (B) Require-
ment of the DEED sequence for cal-
nexin cleavage. EGFP fused to a car-
boxyl terminal region of calnexin with
or without alteration of the DXXD
sequence was expressed in COS-1
cells, and then lysates containing 20
µg of protein after staurosporine
treatment for 48 h were analyzed by
immunoblotting. (C) Cleavage at the
DEED sequence. EGFP fused to a por-
tion of calnexin including only the
DEED sequence was expressed in
COS-1 cells and analyzed as in B. (D
and E) Cleavage by caspases. EGFP-
fused proteins (as described in C) (D),
or an entire region of mouse calnexin
(E), were synthesized in vitro, treated
with the indicated active caspases,
and separated by SDS-PAGE. A fluor-
ogram of the gel is shown. A lysate of
staurosporine-treated cells was
simultaneously separated by SDS-
PAGE and analyzed by Western blot-
ting (WB).J. Biochem.
Calnexin Cleavage during Apoptosis 403examined after treatment with tunicamycin (Fig. 5).
Most cells expressing EGFP alone appeared shrunken,
rounded and apoptotic following exposure to tunicamy-
cin. However, these changes in cells expressing the
cleaved calnexin were reduced to about 60% of those in
cells expressing EGFP alone, considering that the pro-
portion of spontaneously dying cells without the reagent
was about 20% (Fig. 5B). In contrast, preliminary results
indicated that the fused protein did not inhibit stau-
rosporine-induced morphological changes (data not shown).
These results suggest that the cleaved product of cal-
nexin attenuates, at least, ER stress–induced apoptosis.
We next examined the expression of the transcription
factor CHOP in the same cells by immunoblotting. As
observed above (Fig. 2), tunicamycin treatment induced
the expression of CHOP, and this was partly inhibited
when the cleaved product of calnexin was present (about
60% of control as assessed by densitometry) (Fig. 6). This
effect of the cleaved product on CHOP expression may be
underestimated since the efficiency of the transient
transfection was about 30% or less. Essentially the same
results were observed when cells were exposed to thapsi-
gargin or A23187 (data not shown).
DISCUSSION
ER stress leads to the induction of apoptosis via the acti-
vation of caspase-12 (7, 8). Caspase-12 could thus be a
candidate for the enzyme that cleaves calnexin. However,
our study showed that the sequence DEED located near
the carboxyl terminus of calnexin is most likely to be the
site of cleavage, and this sequence does not match the
target sequence of caspase-12. The sequence DEED could
be targeted by group II caspases (20), and, indeed, recom-
binant caspase-3, and probably caspase-7 as well,
directly proteolysed calnexin in vitro. In addition, cal-
nexin cleavage was observed in cells undergoing apopto-
sis not accompanied by ER stress. Collectively, it is most
likely that calnexin is subjected to proteolysis at a site
near the carboxyl terminus by caspase-3 or caspase-7 in
Fig. 5. Inhibition of apoptosis and ER stress by
cleaved calnexin. NIH3T3 cells were transfected
with DNA expressing EGFP alone (EGFP) or EGFP
fused to the carboxyl terminal region spanning amino
acids 567 to 591 (EGFP-calnx), incubated in the pres-
ence (+) or absence (–) of tunicamycin for 24 h, and
analyzed for the occurrence of apoptosis. (A) Cells were
examined by fluorescence microscopy. Representative
fluorescence and phase contrast images of the same
microscopic fields are shown at a magnification of 400.
Arrows in the phase contrast images indicate fluores-
cence-positive cells. (B) The number of shrunken cells
among fluorescence-positive cells was determined and
expressed as the extent of apoptosis. The means ± SD
from three independent experiments are shown.Vol. 136, No. 3, 2004
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site, since the preferential peptide substrates of caspase-
2 are different from those of caspase-3 and caspase-7 (5).
Calnexin was cleaved into smaller fragments upon expo-
sure to staurosporine or A23187 (Fig. 1), indicating the
existence of an additional cleavage site. Judging from the
size of the smaller fragment, the site seems to exist in the
ER luminal domain. Since there is no sequence that
matches the caspase cleavage sites in the ER luminal
domain (10), caspases are unlikely to cleave this site.
Further analysis is required to clarify this issue.
The mechanism by which the cleaved product of cal-
nexin inhibits apoptosis, if it occurs at all, remains to be
clarified. Our data indicate that the expression of the
transcription factor CHOP, which is induced by ER stress
(19), was inhibited in cells upon overexpression of a pre-
sumed cleavage product of calnexin. It is thus possible
that calnexin-mediated attenuation of apoptosis is
accompanied by the inhibition of CHOP expression. How-
ever, this cannot be the general mechanism since cal-
nexin cleavage occurs in apoptotic cells with no evidence
of a response to ER stress. Moreover, while the induction
of CHOP begins early (within 8 h after ER stress), cal-
nexin cleavage occurs relatively late in apoptosis. There-
fore, it seems likely that the cleaved product of calnexin
does not inhibit the expression of CHOP directly, but
rather suppresses it indirectly by reducing apoptosis dur-
ing an ER stress.
In contrast, calnexin-deficient cells are relatively
resistant to ER stress–induced apoptosis (21). It has been
explained that the cleavage of Bap31, whose product p20
induces apoptosis, is inhibited in calnexin-deficient cells,
since the cytoplasmic tail of calnexin may play a role in
caspase 8–dependent cleavage of Bap31 (21). It is thus
conceivable that the cytoplasmic tail of calnexin may
mediate the Bap31-calnexin interaction and the cleavage
of the cytoplasmic tail might reduce the generation of p20
with a resultant attenuation of Bap31-dependent apopto-
sis. Overexpression of the EGFP-calnexin tail might com-
pete for the Bap31-calnexin interaction. Further analy-
ses are required to clarify this hypothesis. That calnexin
lacking an ER retention signal changes its subcellular
localization to the Golgi apparatus or the cell surface (22)
suggests an unexpected mechanism for the calnexin-
mediated inhibition of apoptosis.
Another ER chaperone, calreticulin, has been sug-
gested to induce apoptosis (23) and to be involved in the
recognition of apoptotic cells by phagocytes (24).
Although it is not known if calreticulin undergoes prote-
olysis and a change in subcellular localization during
apoptosis, ER chaperones thus could be generally
involved in apoptotic events.
In summary, the findings obtained in this study lead us
to propose a novel mechanism for the control of apoptosis:
the cytoplasmic domain of the ER chaperone calnexin is
liberated by caspases in apoptosing cells and acts to
attenuate apoptosis. Further studies are needed to con-
firm this issue.
We are grateful to Dr. Larry W. Tjoelker for providing mouse
calnexin cDNA. This work was supported in part by a Grant-
in-Aid for Scientific Research from the Ministry of Education,
Science, Sports, and Culture, Japan.
REFERENCES
1. Sambrook, J.F. (1990) The involvement of calcium in transport
of secretory proteins from the endoplasmic reticulum. Cell 61,
197–199
2. Mattson, M.P., LaFerla, F.M., Chan, S.L., Leissring, M.A.,
Shepel, P.N., and Geiger, J.D. (2000) Calcium signaling in the
ER: its role in neuronal plasticity and neurodegenerative dis-
orders. Trends Neurosci. 23, 222–229
3. Kaufman, R.J. (1999) Stress signaling from the lumen of the
endoplasmic reticulum: coordination of gene transcriptional
and translational controls. Genes Dev. 13, 1211–1233
4. Sherman, M.Y. and Goldberg, A.L. (2001) Cellular defenses
against unfolded proteins: a cell biologist thinks about neuro-
degenerative diseases. Neuron 29, 15–32
5. Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H. (1999)
Mammalian caspases: structure, activation, substrates, and
functions during apoptosis. Annu. Rev. Biochem. 68, 383–424
6. Thornberry, N.A. and Lazebnik, Y. (1998) Caspases: enemies
within. Science 281, 1312–1316
7. Nakagawa, T. and Yuan, J. (2000) Cross-talk between two
cysteine protease families. Activation of caspase-12 by calpain
in apoptosis. J. Cell Biol. 150, 887–894
8. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner,
B.A., and Yuan, J. (2000) Caspase-12 mediates endoplasmic-
reticulum–specific apoptosis and cytotoxicity by amyloid-beta.
Nature 403, 98–103
9. Rao, R.V., Hermel, E., Castro-Obregon, S., del Rio, G., Ellerby,
L.M., Ellerby, H.M., and Bredesen, D.E. (2001) Coupling endo-
plasmic reticulum stress to the cell death program. Mechanism
of caspase activation. J. Biol. Chem. 276, 33869–33874
10. Tjoelker, L.W., Seyfried, C.E., Eddy, R.L. Jr., Byers, M.G.,
Shows, T.B., Calderon, J., Schreiber, R.B., and Gray, P.W. (1994)
Human, mouse, and rat calnexin cDNA cloning: identification
of potential calcium binding motifs and gene localization to
human chromosome 5. Biochemistry 33, 3229–3236
11. Bergeron, J.J., Brenner, M.B., Thomas, D.Y. and Williams, D.B.
(1994) Calnexin: a membrane-bound chaperone of the endo-
plasmic reticulum. Trends Biochem. Sci. 19, 124–128
Fig. 6. Inhibition of CHOP expression by cleaved calnexin.
NIH3T3 cells were transfected with DNA expressing EGFP alone
(EGFP) or EGFP fused to the carboxyl terminal region (EGFP-
calnx) as indicated in Fig. 5, and incubated in the presence (+) or
absence (–) of tunicamycin for 8 h. (A) Cells were lysed and ana-
lyzed for the expression of CHOP and EGFP-fusion proteins by
immunoblotting. The arrowheads indicate the positions of CHOP
and EGFP-fusion proteins. (B) The intensity of CHOP signals was
determined, and that in lysates with the fusion protein is shown rel-
ative to that with EGFP alone. The means ± SD from three inde-
pendent experiments are shown.J. Biochem.
Calnexin Cleavage during Apoptosis 40512. High, S., Lecomte, F.J., Russell, S.J., Abell, B.M. and Oliver,
J.D. (2000) Glycoprotein folding in the endoplasmic reticulum:
a tale of three chaperones? FEBS Lett. 476, 38–41
13. Takizawa, T., Matsukawa, S., Higuchi, Y., Nakamura, S.,
Nakanishi, Y. and Fukuda, R. (1993) Induction of programmed
cell death (apoptosis) by influenza virus infection in tissue cul-
tured cells. J. Gen. Virol. 74, 2347–2355
14. Cormack, B. (1991) Current Protocols in Molecular Biology
(Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Sei-
dman, J.G., Smith, J.A., and Struhl, K., eds.) pp. 8.57–8.58,
John Wiley and Sons, Inc., New York
15. Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequenc-
ing with chain-terminating inhibitors. Proc. Natl Acad. Sci.
USA 74, 5463–5467
16. Takizawa, T., Tatematsu, C. and Nakanishi, Y. (1999) Double-
stranded RNA–activated protein kinase (PKR) fused to green
fluorescent protein induces apoptosis of human embryonic kid-
ney cells: possible role in the Fas signaling pathway. J. Bio-
chem. 125, 391–398
17. Laemmli, U. (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227, 680–
685
18. Takizawa, T., Tatematsu, C., Ohashi, K., and Nakanishi, Y.
(1999) Recruitment of apoptotic cysteine proteases (caspases)
in influenza virus–induced cell death. Microbiol. Immunol. 43,
245–252
19. Wang, X.Z., Lawson, B., Brewer, J.W., Zinszner, H., Sanjay, A.,
Mi, L.J., Boorstein, R., Kreibich, G., Hendershot, L.M., and
Ron, D. (1996) Signals from the stressed endoplasmic reticu-
lum induce C/EBP-homologous protein (CHOP/GADD153).
Mol. Cell. Biol. 16, 4273–4280
20. Nicholson, D.W. and Thornberry, N.A. (1997) Caspases: killer
proteases. Trends Biochem. Sci. 22, 299–306
21. Zuppini, A., Groenendyk, J., Cormack, L.A., Shore, G., Opas,
M., Bleackley, R.C., and Michalak, M. (2002) Calnexin defi-
ciency and endoplasmic reticulum stress-induced apoptosis.
Biochemistry 41, 2850–2858
22. Rajagopalan, S., Xu, Y., and Brenner, M.B. (1994) Retention of
unassembled components of integral membrane proteins by
calnexin. Science 263, 387–390
23. Kageyama, K., Ihara, Y., Goto, S., Urata, Y., Toda, G., Yano, K.,
and Kondo, T. (2002) Overexpression of calreticulin modulates
protein kinase B/Akt signaling to promote apoptosis during
cardiac differentiation of cardiomyoblast H9c2 cells. J. Biol.
Chem. 277, 19255–19264
24. Ogden, C.A., deCathelineau, A., Hoffmann, P.R., Bratton, D.,
Ghebrehiwet, B., Fadok, V.A., and Henson, P.M. (2001) C1q
and mannose binding lectin engagement of cell surface calreti-
culin and CD91 initiates macropinocytosis and uptake of apop-
totic cells. J. Exp. Med. 194, 781–795Vol. 136, No. 3, 2004
